Literature DB >> 11435588

N-terminal domain of Borna disease virus G (p56) protein is sufficient for virus receptor recognition and cell entry.

M Perez1, M Watanabe, M A Whitt, J C de la Torre.   

Abstract

Borna disease virus (BDV) surface glycoprotein (GP) (p56) has a predicted molecular mass of 56 kDa. Due to extensive posttranslational glycosylation the protein migrates as a polypeptide of 84 kDa (gp84). The processing of gp84 by the cellular protease furin generates gp43, which corresponds to the C-terminal part of gp84. Both gp84 and gp43 have been implicated in viral entry involving receptor-mediated endocytosis and pH-dependent fusion. We have investigated the domains of BDV p56 involved in virus entry. For this, we used a pseudotype approach based on a recently developed recombinant vesicular stomatitis virus (VSV) in which the gene for green fluorescent protein was substituted for the VSV G protein gene (VSV Delta G*). Complementation of VSV Delta G* with BDV p56 resulted in infectious VSV Delta G* pseudotypes that contained both BDV gp84 and gp43. BDV-VSV chimeric GPs that contained the N-terminal 244 amino acids of BDV p56 and amino acids 421 to 511 of VSV G protein were efficiently incorporated into VSV Delta G* particles, and the resulting pseudotype virions were neutralized by BDV-specific antiserum. These findings indicate that the N-terminal part of BDV p56 is sufficient for receptor recognition and virus entry.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11435588      PMCID: PMC114436          DOI: 10.1128/JVI.75.15.7078-7085.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  High-efficiency incorporation of functional influenza virus glycoproteins into recombinant vesicular stomatitis viruses.

Authors:  E Kretzschmar; L Buonocore; M J Schnell; J K Rose
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Functional role of hepatitis C virus chimeric glycoproteins in the infectivity of pseudotyped virus.

Authors:  L M Lagging; K Meyer; R J Owens; R Ray
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

3.  Processing of the Borna disease virus glycoprotein gp94 by the subtilisin-like endoprotease furin.

Authors:  J A Richt; T Fürbringer; A Koch; I Pfeuffer; C Herden; I Bause-Niedrig; W Garten
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

4.  Borna disease virus in brains of North American and European people with schizophrenia and bipolar disorder. Bornavirus Study Group.

Authors:  M Salvatore; S Morzunov; M Schwemmle; W I Lipkin
Journal:  Lancet       Date:  1997-06-21       Impact factor: 79.321

5.  Detection of Borna disease virus (BDV) antibodies and BDV RNA in psychiatric patients: evidence for high sequence conservation of human blood-derived BDV RNA.

Authors:  C Sauder; A Müller; B Cubitt; J Mayer; J Steinmetz; W Trabert; B Ziegler; K Wanke; N Mueller-Lantzsch; J C de la Torre; F A Grässer
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

6.  A system for functional analysis of Ebola virus glycoprotein.

Authors:  A Takada; C Robison; H Goto; A Sanchez; K G Murti; M A Whitt; Y Kawaoka
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

7.  Attenuation of recombinant vesicular stomatitis viruses encoding mutant glycoproteins demonstrate a critical role for maintaining a high pH threshold for membrane fusion in viral fitness.

Authors:  B L Fredericksen; M A Whitt
Journal:  Virology       Date:  1998-01-20       Impact factor: 3.616

8.  Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines.

Authors:  R J Wool-Lewis; P Bates
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

9.  Recombinant vesicular stomatitis virus expressing respiratory syncytial virus (RSV) glycoproteins: RSV fusion protein can mediate infection and cell fusion.

Authors:  J S Kahn; M J Schnell; L Buonocore; J K Rose
Journal:  Virology       Date:  1999-02-01       Impact factor: 3.616

10.  Mechanism of Borna disease virus entry into cells.

Authors:  D Gonzalez-Dunia; B Cubitt; J C de la Torre
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

View more
  29 in total

1.  Identification of the lymphocytic choriomeningitis virus (LCMV) proteins required to rescue LCMV RNA analogs into LCMV-like particles.

Authors:  Ki Jeong Lee; Mar Perez; Daniel D Pinschewer; Juan Carlos de la Torre
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

2.  A novel borna disease virus vector system that stably expresses foreign proteins from an intercistronic noncoding region.

Authors:  Takuji Daito; Kan Fujino; Tomoyuki Honda; Yusuke Matsumoto; Yohei Watanabe; Keizo Tomonaga
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

3.  Cells expressing the RING finger Z protein are resistant to arenavirus infection.

Authors:  Tatjana I Cornu; Heinz Feldmann; Juan Carlos de la Torre
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

4.  Characterization of the interaction of lassa fever virus with its cellular receptor alpha-dystroglycan.

Authors:  Stefan Kunz; Jillian M Rojek; Mar Perez; Christina F Spiropoulou; Michael B A Oldstone
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

5.  Posttranslational modification of alpha-dystroglycan, the cellular receptor for arenaviruses, by the glycosyltransferase LARGE is critical for virus binding.

Authors:  Stefan Kunz; Jillian M Rojek; Motoi Kanagawa; Christina F Spiropoulou; Rita Barresi; Kevin P Campbell; Michael B A Oldstone
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

6.  Generation and characterization of a recombinant vesicular stomatitis virus expressing the glycoprotein of Borna disease virus.

Authors:  Mar Perez; Roberto Clemente; Clinton S Robison; E Jeetendra; Himangi R Jayakar; Michael A Whitt; Juan C de la Torre
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

7.  Cell-to-cell spread of Borna disease virus proceeds in the absence of the virus primary receptor and furin-mediated processing of the virus surface glycoprotein.

Authors:  Roberto Clemente; Juan C de la Torre
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

8.  Molecular chaperone BiP interacts with Borna disease virus glycoprotein at the cell surface.

Authors:  Tomoyuki Honda; Masayuki Horie; Takuji Daito; Kazuyoshi Ikuta; Keizo Tomonaga
Journal:  J Virol       Date:  2009-09-23       Impact factor: 5.103

9.  Persistence of Borna disease virus in naturally infected sheep.

Authors:  Thomas W Vahlenkamp; Andrea Konrath; Matthias Weber; Hermann Müller
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

10.  Proteomics computational analyses suggest that the bornavirus glycoprotein is a class III viral fusion protein (gamma penetrene).

Authors:  Courtney E Garry; Robert F Garry
Journal:  Virol J       Date:  2009-09-18       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.